Filing Details

Accession Number:
0001209191-12-051911
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-06 16:02:51
Reporting Period:
2012-11-05
Filing Date:
2012-11-06
Accepted Time:
2012-11-06 16:02:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478485 M Peter Hecht C/o Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2012-11-05 50,000 $11.65 72,803 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 2,985 Indirect The 2000 Trust for Malcolm Paul Hecht
Class A Common Stock 2,985 Indirect The 2000 Trust for Zoe Niovi Hecht
Class A Common Stock 2,985 Indirect The 2000 Trust for Alexis Mae Hecht
Class B Common Stock 3,649,751 Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.36 to $11.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.